Bacterial Meningitis

Bacterial meningitis is acute bacterial infection of the meninges and the cerebrospinal fluid surrounding the brain and spinal cord. It is a medical emergency: the inflammatory response within the closed cranial space can cause rapid neurological deterioration, and outcome is closely tied to how quickly effective treatment is begun, which is why it sits at the intersection of critical care and antimicrobial therapy.

Definition

Bacterial meningitis is acute inflammation of the meninges (the leptomeninges) caused by bacterial infection of the subarachnoid space and cerebrospinal fluid, classically presenting with a combination of fever, headache, neck stiffness, and altered mental status.

Scope

This topic covers the nature of meningeal infection, the principal causative organisms, the pathophysiology of the inflammatory response within the central nervous system, and why timing of therapy is central to the syndrome. It treats bacterial meningitis as a clinical entity at the conceptual level and is reference material; it does not provide diagnostic algorithms, antibiotic selection, dosing, or treatment instructions.

Core questions

• How does bacterial infection of the cerebrospinal fluid produce rapid neurological injury?
• Which organisms most commonly cause community-acquired bacterial meningitis, and how does this differ by host?
• Why is the speed of effective antimicrobial therapy so consequential in meningitis?
• How is bacterial meningitis distinguished conceptually from viral and other forms of meningitis?

Key concepts

• Meninges and the subarachnoid space
• Cerebrospinal fluid inflammation
• Common pathogens (e.g., Streptococcus pneumoniae, Neisseria meningitidis)
• Raised intracranial pressure
• Meningismus (fever, headache, neck stiffness)
• Time-critical antimicrobial therapy
• Community-acquired versus healthcare-associated meningitis

Mechanisms

Bacteria reach the subarachnoid space most often by haematogenous spread after nasopharyngeal colonization, or by direct extension from adjacent infection or breaches such as trauma or neurosurgery. Within the cerebrospinal fluid, where host defences are sparse, organisms multiply and trigger an intense inflammatory cascade; this inflammation, rather than the bacteria alone, drives cerebral oedema, raised intracranial pressure, impaired cerebral blood flow, and neuronal injury (van de Beek 2006). Because the infection is enclosed and progresses quickly, delay in effective antimicrobial therapy allows further bacterial proliferation and inflammation, consistent with the broader observation that delayed effective therapy worsens outcome in severe infection (Kumar 2006).

Clinical relevance

Bacterial meningitis is among the infections in which time to effective therapy most directly affects survival and neurological outcome, and it frequently requires critical-care support for raised intracranial pressure, seizures, and systemic complications. This entry describes the entity and its pathophysiology for reference; it is educational and does not provide diagnostic criteria, antibiotic or adjunctive regimens, dosing, or any individualized treatment guidance.

Epidemiology

In adults, community-acquired bacterial meningitis is caused predominantly by Streptococcus pneumoniae and Neisseria meningitidis, with the relative frequency of organisms varying by age, vaccination coverage, and host factors; healthcare-associated and post-neurosurgical meningitis involve a different microbial spectrum. Despite effective antimicrobials, the disease still carries substantial mortality and a high rate of neurological sequelae among survivors (van de Beek 2006; Tunkel 2004).

History

Bacterial meningitis was almost uniformly fatal before effective antimicrobials; the introduction of antibiotics and, later, conjugate vaccines against the leading pathogens transformed its epidemiology and outcome. The IDSA practice guidelines (Tunkel 2004) and contemporary reviews (van de Beek 2006) codified the modern understanding of the disease, its causative organisms, and the central importance of early effective therapy.

Debates

What is the role of adjunctive corticosteroids in bacterial meningitis?

Because much of the injury is driven by the inflammatory response, dampening that response with adjunctive corticosteroids has been studied as a way to reduce harm, but the benefit varies by causative organism, host, and setting, and remains a point of ongoing discussion.

Seminal works

• vandebeek-2006
• tunkel-2004

Frequently asked questions

Why is bacterial meningitis treated as an emergency?

The infection sits in the enclosed space around the brain and spinal cord and provokes intense inflammation that can rapidly raise intracranial pressure and injure the brain; outcome is closely tied to how quickly effective treatment begins, so it is approached as a time-critical condition.

How does bacterial meningitis differ from viral meningitis?

Both involve inflammation of the meninges, but bacterial meningitis is caused by bacteria and is typically far more severe and rapidly progressive, whereas viral (aseptic) meningitis is usually less severe; this entry describes the distinction conceptually and is not a basis for diagnosing the cause in an individual patient.